Serotonin increases ERK1/2 phosphorylation in astrocytes by stimulation of 5-HT2B and 5-HT2C receptors

Neurochemistry International

Volumn 57, Issue 4, 2010, Pages 432-439

  Li, Baoman ^a   Zhang, Shiquen ^a   Li, Min ^a   Hertz, Leif ^a   Peng, Liang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Astrocytic receptors; EGF receptor; Extracellular regulated kinases 1 2; Transactivation

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; ILOMASTAT; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SEROTONIN; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; ZINC; DIPEPTIDE; PROTEINASE INHIBITOR; SMALL INTERFERING RNA; TYRPHOSTIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN REGION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; TRANSACTIVATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME SPECIFICITY; METABOLISM; PHOSPHORYLATION; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; CELLS, CULTURED; DIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTEASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, SEROTONIN, 5-HT2B; RECEPTOR, SEROTONIN, 5-HT2C; RNA, SMALL INTERFERING; SEROTONIN; SUBSTRATE SPECIFICITY; TRANSCRIPTIONAL ACTIVATION; TYRPHOSTINS;

EID: 77956231925     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.04.017     Document Type: Article

References (48)

1. Anderson G.M., Teff K.L., Young S.N. Serotonin in cisternal cerebrospinal fluid of the rat: measurement and use as an index of functionally active serotonin. Life Sci. 1987, 40:2253-2260.
2. Anderson G.M., Barr C.S., Lindell S., Durham A.C., Shifrovich I., Higley J.D. Time course of the effects of the serotonin-selective reuptake inhibitor sertraline on central and peripheral serotonin neurochemistry in the rhesus monkey. Psychopharmacology (Berl.) 2005, 178:339-346.
3. Baez M., Kursar J.D., Helton L.A., Wainscott D.B., Nelson D.L. Molecular biology of serotonin receptors. Obes. Res. 1995, 4:441S-447S.
4. Bonaventure P., Nepomuceno D., Miller K., Chen J., Kuei C., Kamme F., Tran D.T., Lovenberg T.W., Liu C. Molecular and pharmacological characterization of serotonin 5-HT2A and 5-HT2B receptor subtypes in dog. Eur. J. Pharmacol. 2005, 513:181-192.
5. Bonhaus D.W., Bach C., De-Souza A., Salazar F.H., Matsuoka B.D., Zuppan P., Chan H.W., Eglen R.M. The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors. Br. J. Pharmacol. 1995, 115:622-628.
6. Cahoy J.D., Emery B., Kaushal A., Foo L.C., Zamanian J.L., Christopherson K.S., Xing Y., Lubischer J.L., Krieg P.A., Krupenko S.A., Thompson W.J., Barres B.A. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 2008, 28:264-278.
7. 2C receptor in glial cells. Brain Res. Bull. 1995, 38:153-159.
8. Choi D.S., Maroteaux L. Immunohistochemical localisation of the serotonin 5-HT2B receptor in mouse gut, cardiovascular system, and brain. FEBS Lett. 1996, 391:45-51.
9. Choi D.S., Ward S.J., Messadeqq N., Launay J.M., Maroteaux L. 5-HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells. Development 1997, 124:174-1756.
10. 2+ responses in rat primary astrocyte cultures. J. Neurosci. Res. 1993, 35:246-256.
11. Doly S., Valjent E., Setola V., Callebert J., Hervé D., Launay J.M., Maroteaux L. Serotonin 5-HT2B receptors are required for 3,4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro. J. Neurosci. 2008, 28:2933-2940.
12. Doly S., Bertran-Gonzalez J., Callebert J., Bruneau A., Banas S.M., Belmer A., Boutourlinsky K., Hervé D., Launay J.M., Maroteaux L. Role of serotonin via 5-HT2B receptors in the reinforcing effects of MDMA in mice. PLoS One 2009, 4:e7952.
13. Du T., Song D., Li H., Li B., Cai L., Hertz L., Peng L. Stimulation by vasopressin of ERK phosphorylation and vector-driven water flux in astrocytes is transactivation-dependent. Eur. J. Pharmacol. 2008, 587:73-77.
14. Duxon M.S., Kennett G.A., Lightowler S., Blackburn T.P., Fone K.C. Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system. Neuroscience 1997, 76:323-329.
15. Dziedzic B., Prevot V., Lomniczi A., Jung H., Cornea A., Ojeda S.R. Neuron-to-glia signaling mediated by excitatory amino acid receptors regulates ErbB receptor function in astroglial cells of the neuroendocrine brain. J. Neurosci. 2003, 223:915-926.
16. el-Marjou A., Delouvee A., Thiery J.P., Radvanyi F. Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression. Carcinogenesis 2000, 21:2211-2218.
17. Gibbs M.E., Hutchinson D., Hertz L. Astrocytic involvement in learning and memory consolidation. Neurosci. Biobehav. Rev. 2008, 32:927-944.
18. Glausier J.R., Maddox M., Hemmings H.C., Nairn A.C., Greengard P., Muly E.C. Localization of dopamine- and cAMP-regulated phosphoprotein-32 and inhibitor-1 in area 9 of Macaca mulatta prefrontal cortex. Neuroscience 2010, (epub ahead of print).
19. Grobelny D., Poncz L., Galardy E. Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids. Biochemistry 1992, 31:7152-7154.
20. Hall I.C., Rebec G.V., Hurley L.M. Serotonin in the inferior colliculus fluctuates with behavioral state and environmental stimuli. J. Exp. Biol. 2010, 213:1009-1117.
21. Hertz L., Peng L., Lai J.C. Functional studies in cultured astrocytes. Methods 1998, 16:293-310.
22. Hertz L., Lovatt D., Goldman S.A., Nedergaard M. Adrenoceptors in brain: Cellular gene expression and effects on astrocytic metabolism and [Ca(2+)](i). Neurochem. Int 2010, (Epub ahead of print).
23. Hirst W.D., Cheung N.Y., Rattray M., Price G.W., Wilkin G.P. Serotonin transporters in adult rat brain astrocytes revealed by [3H]5-HT uptake into glial plasmalemmal vesicles. Neurochem. Int. 1998, 33:11-22.
24. Jerman J.C., Brough S.J., Gager T., Wood M., Coldwell M.C., Smart D., Middlemiss D.N. Pharmacological characterisation of human 5-HT2 receptor subtypes. Eur. J. Pharmacol. 2001, 414:23-30.
25. Kalén P., Strecker R.E., Rosengren E., Björklund A. Endogenous release of neuronal serotonin and 5-hydroxyindoleacetic acid in the caudate-putamen of the rat as revealed by intracerebral dialysis coupled to high-performance liquid chromatography with fluorimetric detection. J. Neurochem. 1998, 51:1422-1435.
26. Kong E.K., Peng L., Chen Y., Yu A.C., Hertz L. Up-regulation of 5-HT2B receptor density and receptor-mediated glycogenolysis in mouse astrocytes by long-term fluoxetine administration. Neurochem. Res. 2002, 27:113-120.
27. Kursar J.D., Nelson D.L., Wainscott D.B., Baez M. Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine 2B receptor. Mol. Pharmacol. 1994, 46:227-234.
28. Levitzki A., Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science 1995, 267:1782-1788.
29. Li B., Du T., Li H., Gu L., Zhang H., Huang J., Hertz L., Peng L. Signalling pathways for transactivation by dexmedetomidine of epidermal growth factor receptors in astrocytes and its paracrine effect on neurons. Br. J. Pharmacol. 2008, 154:191-203.
30. Li B., Zhang S., Zhang H., Niu W., Cai L., Hertz L., Peng L. Fluoxetine-mediated 5-HT2B receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation. Psychopharmacology (Berl.) 2008, 201:443-458.
31. Liang Y.J., Lai L.P., Wang B.W., Juang S.J., Chang C.M., Leu J.G., Shyu K.G. Mechanical stress enhances serotonin 2B receptor modulating brain natriuretic peptide through nuclear factor-κB in cardiomyocytes. Cardiovasc. Res. 2006, 72:303-312.
32. Lovatt D., Sonnewald U., Waagepetersen H.S., Schousboe A., He W., Lin J.H., Han X., Takano T., Wang S., Sim F.J., Goldman S.A., Nedergaard M. The transcriptome and metabolic gene signature of protoplasmic astrocytes in the adult murine cortex. J. Neurosci. 2007, 27:12255-12266.
33. Manivet P., Mouillet-Richard S., Callebert J., Nebigil C.G., Maroteaux L., Hosoda S., Kellermann O., Launay J.M. PDZ-dependent activation of nitric-oxide synthases by the serotonin 2B receptor. J. Biol. Chem. 2000, 275:9324-9331.
34. Manivet P., Schneider B., Smith J.C., Choi D.S., Maroteaux L., Kellermann O., Launay J.M. The serotonin binding site of human and murine 5-HT2B receptors: molecular modeling and site-directed mutagenesis. J. Biol. Chem. 2002, 277:17170-17178.
35. Meier E., Hertz L., Schousboe A. Neurotransmitters as developmental signals. Neurochem. Int. 1991, 19:1-15.
36. Merzak A., Koochekpour S., Fillion M.P., Fillion G., Pilkington G.J. Expression of serotonin receptors in human fetal astrocytes and glioma cell lines: a possible role in glioma cell proliferation and migration. Mol. Brain Res. 1996, 41:1-7.
37. Müller C.P., De-Souza-Silva M.A., Huston J.P. Double dissociating effects of sensory stimulation and cocaine on serotonin activity in the occipital and temporal cortices. Neuropharmacology 2007, 52:854-862.
38. Pälvimäki E.P., Roth B.L., Majasuo H., Laakso A., Kuoppamäki M., Syvälahti E., Hietala J. Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor. J. Psychopharmacol. (Berl.) 1996, 126:234-240.
39. Peng L., Li B., Du T., Kong E.K.C., Hu X., Zhang S., Shan X., Zhang M. Astrocytes transactivation by alpha2-adrenergic and 5-HT2B serotonergic signaling. Neurochem. Int. 2010, 57:421-431.
40. Peng L., Yu A.C.H., Fung K.Y., Prevot V., Hertz L. α-Adrenergic stimulation of ERK phosphorylation in astrocytes is α2-specific and may be mediated by transactivation. Brain Res. 2003, 978:65-71.
41. Porter R.H., Benwell K.R., Lamb H., Malcolm C.S., Allen N.H., Revell D.F., Adams D.R., Sheardown M.J. Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells. Br. J. Pharmacol. 1999, 128:13-20.
42. Pum M.E., Huston J.P., De-Souza-Silva M.A., Müller C.P. Visual sensory-motor gating by serotonin activation in the medial prefrontal and occipital, but not in the rhinal, cortices in rats. Neuroscience 2008, 153:361-372.
43. Roth B.L., Willins D.L., Kristiansen K., Kroeze W.K. 5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function. Pharmacol. Ther. 1998, 79:231-257.
44. Samuels I.S., Karlo J.C., Faruzzi A.N., Pickering K., Herrup K., Sweatt J.D., Saitta S.C., Landreth G.E. Deletion of ERK2 mitogen-activated protein kinase identifies its key roles in cortical neurogenesis and cognitive function. J. Neurosci. 2008, 28:6983-6995.
45. 2+ increases in cultured astrocytes from three different brain regions. Neurochem. Int. 2000, 36:427-434.
46. Sweatt J.D. Protooncogenes subserve memory formation in the adult CNS. Neuron 2001, 31:671-674.
47. Wong E.H., Clark R., Leung E., Loury D., Bonhaus D.W., Jakeman L., Parnes H., Whiting R.L., Eglen R.M. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro. Br. J. Pharmacol. 1995, 114:851-859.
48. Young S.N., Anderson G.N. Bioanalytical inaccuracy: a threat to the integrity and efficiency of research. J. Psychiatry Neurosci. 2010, 35:3-6.